Management of Vulvovaginal Candidiasis

Classification and Diagnosis

Vulvovaginal candidiasis can be classified as uncomplicated or complicated, with uncomplicated cases typically caused by Candida albicans in immunocompetent women, and complicated cases including severe symptoms, recurrent disease, non-albicans Candida species, or infection in an abnormal host 1, 2
Proper diagnosis requires clinical evaluation for symptoms such as pruritus, irritation, and vaginal discharge, physical examination for signs like vulvar edema and erythema, laboratory confirmation with wet-mount preparation and potassium hydroxide, and vaginal cultures for patients with negative wet-mount findings or suspected non-albicans species 2

For uncomplicated vulvovaginal candidiasis, either topical antifungal agents or a single 150-mg oral dose of fluconazole is recommended as first-line therapy, with both approaches showing equivalent efficacy of >90% response 3, 4
The Infectious Diseases Society of America recommends fluconazole 150 mg every 72 hours for 2-3 doses for severe acute vulvovaginal candidiasis 4, 5
For complicated vulvovaginal candidiasis with non-albicans species, such as C. glabrata, treatment options include topical intravaginal boric acid, nystatin intravaginal suppositories, or topical 17% flucytosine cream alone or combined with 3% amphotericin B cream 4, 6, 7

The Centers for Disease Control and Prevention notes that treatment should not differ based on HIV status, with identical response rates expected for HIV-positive and HIV-negative women 3, 2
The American College of Obstetricians and Gynecologists recommends monitoring for recurrence after maintenance therapy, as recurrence rates of 40-50% are common 2

The Infectious Diseases Society of America warns against misdiagnosis, as symptoms of vulvovaginal candidiasis are nonspecific and can be caused by various infectious and non-infectious etiologies, and laboratory confirmation is essential, especially for recurrent cases 2
The American College of Obstetricians and Gynecologists advises against inadequate treatment duration, as complicated vulvovaginal candidiasis requires longer treatment courses than uncomplicated vulvovaginal candidiasis 3, 4

The Infectious Diseases Society of America recommends the use of topical azole therapy for 7 days in pregnant women, as oral fluconazole is contraindicated due to association with spontaneous abortion 8
Vaginal pH ≤4.5 is suggested to confirm diagnosis, with higher pH indicating bacterial vaginosis or trichomoniasis 8

Alternative/complementary therapies, such as honey-based ointments, essential oils, and ginger-clotrimazole combinations, show equal or inferior results to FDA-approved medications and lack regulation 8

Fluconazole 150 mg weekly for 6 months improves quality of life in 96% of women, though recurrence after discontinuation occurs in >63% of cases 8